| Financial Year |
March 31 2023 |
| Monetary Funds |
1,212,016,682.69 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
4,019,696.91 |
| Advances to Suppliers |
1,015,674.33 |
| Other Receivables |
61,728,528.53 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
7,406,541.80 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
303,038,747.17 |
| Other Current Assets |
166,418,222.16 |
| Total Current Assets |
1,755,644,093.59 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
761,715,638.65 |
| Long-term Equity Investment |
720,542.80 |
| Investment Properties |
125,666,479.25 |
| Fixed Assetes |
53,313,140.33 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
37,026,978.75 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,406,837.75 |
| Deferred Income Tax Assets |
119,549,034.25 |
| Other Non-Current Assets |
33,787,124.53 |
| Sub-Total of Non-Current Assets |
1,557,366,279.17 |
| Total Assets |
3,313,010,372.76 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
3,949,695.29 |
| Accounts Received In Advance |
210,083.00 |
| Employee Compensation Payable |
16,083,050.07 |
| Taxes Payable |
8,654,580.55 |
| Interest Payable |
-- |
| Dividend Payable |
5,007,650.05 |
| Other payables |
22,755,113.90 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
197,405,337.86 |
| Other Current Liabilities |
74,616,695.17 |
| Sub-Total of Current Liabilities |
331,396,967.90 |
| Long-term Loans |
221,080,438.53 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
12,537,121.59 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
2,954,751.69 |
| Sub-Total of Non-Current Liabilities |
242,864,742.50 |
| Total Liabilities |
574,261,710.40 |
| Paid-In Capital(Or Share Stock) |
454,322,747.00 |
| Capital Surplus |
565,849,446.14 |
| Surplus Reserve |
115,373,948.04 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,000,787,832.34 |
| Minority Stockholder's Interest |
615,985,938.84 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,122,762,723.52 |
| Owner's Equity（Stockholder's Equity） |
2,738,748,662.36 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,313,010,372.76 |
